Clinical Study

Efficacy and Safety of Ultrasound-Guided Percutaneous Polidocanol Sclerotherapy in Benign Cystic Thyroid Nodules: Preliminary Results

Table 2

Efficacy of PPI in cystic thyroid nodules at follow-up.

Baseline1 month3 months6 months12 months

Size reduction (%)ā€”<0.001
Success rate, n (%)ā€”42/114 (36.8)102/114 (89.5)112/114 (98.2)114/114 (100)<0.001
Symptom score<0.001
Cosmetic grade<0.001

PPI: percutaneous polidocanol injection.